To promote the healthy development of biomedicine, Yunnan Province issued a number of targeted measures

[policies and regulations of pharmaceutical network] to promote the development of biomedical health industry and traditional Chinese medicine in Yunnan Province, and promote the continuous optimization of business environment Recently, the Medical Security Bureau of Yunnan Province issued several measures to support the development of traditional Chinese medicine and optimize the business environment of Yunnan biomedical health industry, and put forward a number of targeted, innovative and operational measures Measures proposed to fully support the development of biomedical industry Actively support the drugs with Yunnan national characteristics and promoting the development of Yunnan biomedical industry to be included in the national medical insurance drug catalog; study and formulate specific measures for the inclusion of ethnic drugs, Chinese herbal pieces, hospital preparations, etc in Yunnan medical insurance payment; make clear that the insured can use the medical insurance personal account to pay for their own and their relatives' use of non immunization program vaccine products, and Public health institutions and grass-roots medical institutions that provide vaccine injection services are included in the scope of designated medical institutions of medical insurance to ensure that the implementation of medical insurance payment policy is effective, reduce the cost burden of the insured, and meet diversified health needs At the same time, the measures also proposed to fully support the development of traditional Chinese medicine Taking "adjusting payment categories and improving supporting policies" as the starting point, we will support the development of traditional Chinese medicine by expanding the scope of medical insurance payment and increasing the proportion of reimbursement Adjust the payment category of Chinese herbal pieces, do not set the proportion of personal first pay, and simultaneously include Chinese herbal pieces into the scope of use of chronic diseases and special diseases in the basic medical insurance outpatient of urban and rural workers and residents; gradually include the eligible non drug treatment projects of traditional Chinese medicine such as acupuncture, cupping, therapeutic massage and the appropriate technology of traditional Chinese medicine into the scope of payment of Yunnan basic medical insurance; implement DRG payment The weight of dominant diseases in traditional Chinese medicine is inclined Yunnan is a province with a large number of plant species, known as the "treasure house of medicine" and "hometown of spices" Among the nearly 30000 kinds of higher plants in China, Yunnan accounts for more than 60% There are 6559 kinds of traditional Chinese medicine resources in the province, accounting for 51.4% of the total number of species in the country The planting area of traditional Chinese medicine reaches 7.94 million mu, with a production of 1.04 million tons, ranking first in the country in terms of planting area and production At the same time, there are more than 2000 kinds of ethnic medicine resources in Yunnan, and more than 10000 folk prescriptions The ethnic medicine of Yunnan, represented by Yi medicine, Miao medicine and Dai medicine, has unique curative effect and strong market prospect and potential In recent years, Yunnan province attaches great importance to the development of biomedical industry, and has issued a series of policies and measures, such as several opinions on promoting the development of Chinese herbal medicine decoction pieces industry, the development plan of biomedical and large health industry, and the construction drawing of biomedical industry Recently, Yunnan Province issued "several measures to support the development of traditional Chinese medicine and optimize the business environment of Yunnan biomedical health industry", which once again created a good environment for the development of Yunnan biomedical industry In addition, the author learned that in 2019, Yunnan Province also issued several opinions on speeding up the high-quality development of biomedical industry to promote the high-quality development of biomedical industry focusing on biotechnology drugs, modern Chinese medicine and generic drugs According to the opinion, Yunnan Province strives to double the number of biomedical enterprises with main business income of more than 1 billion yuan and the main business income of biomedical industry compared with 2018, and the biomedical industry will reach a scale of 100 billion yuan in 2022 According to the opinions, Yunnan Province will implement the three-year doubling plan for the high-quality development of its biomedical industry based on the existing industrial foundation In order to achieve the development goal of the three-year doubling plan, the province has made detailed deployment in key technology research and development, enterprise cultivation, financing arrangement, talent construction, etc
It is understood that in order to better promote the development of the pharmaceutical industry and protect people's health and safety, Yunnan Province will continue to adhere to the problem-based approach, promote the standardization and scientization of policies and measures in the field of medical security, focus on solving pain points, difficulties, blocking points and focus issues, further improve the sense of access, happiness and security of the insured people, and truly focus on the iron industry The gesture of trace stepping stone imprinting helps "healthy Yunnan"